Follow Us on Google
By Chibuike Onyeukwu
In every society, the strength of the healthcare reflects the value placed on human life and dignity. Healthcare facilities are not merely buildings where medicines are dispensed. Rather, they are places where hope is restored and families find relief. It is also a system where the state demonstrates its commitment to the wellbeing of its citizens. For many years, however, the healthcare system in Imo State struggled under the weight of deep structural challenges that threatened its very survival.
Before the present reforms, the state’s hospital management structure, operated under the old Hospital Management Board (HMB), established by military decree in 1978. Over time, the system became increasingly unsustainable. Government-owned hospitals across the state were gradually deteriorating, infrastructure was aging and critical medical equipment was either obsolete or unavailable.
More troubling was the fact that the hospitals were not generating or returning any meaningful revenue to the state government, while public funds continued to flow into the system without commensurate improvement in service delivery.
As a visionary, Dist. Senator Hope Uzodinma CON, GSSI, Governor of Imo State, took a bold and decisive step to rescue the system from total collapse.
Notably, the foundation for these reforms was laid in Governor Uzodinma’s inaugural address, where he outlined a comprehensive healthcare policy focused on strengthening primary, secondary and tertiary healthcare and preventive medicine across the state. He had pledged to pursue a comprehensive medicare programme aimed at achieving widespread “Health for All” coverage across the 27 local government areas, while prioritizing the recruitment of skilled manpower, upgrade of infrastructure, modernization and equipping of the hospitals with advanced diagnostic facilities and the adoption of a value-based healthcare system.
Other News
Recognizing that the existing structure was no longer sustainable, towards achieving the vision, Governor Uzodinma initiated a fundamental reform by repealing the outdated legal framework. This gave birth to the Heartland Hospitals Management Corporation (HHMC) in April 2025, established by a new law of the Imo State House of Assembly.
The HHMC, according to the law, is mandated to oversee the administration, coordination and development of government-owned hospitals, agencies and institutions in Imo State, ensuring efficient management, improved healthcare delivery and the availability of modern medical infrastructure. Through effective supervision and strategic partnerships, the Corporation works to strengthen public health facilities and expand access to quality, affordable medical care for residents across the state.
The reform introduced a transformative Public-Private Partnership (PPP) model to be coordinated by the Corporation. The partnership will ensure the upgrading of hospital infrastructure, provision of expertise in service delivery, manpower development and modern medical equipment. It is designed to operate on a sustainable model where both investors and the state generate value, unlocking healthcare as both a social good and a major revenue earner.
Governor Uzodinma has been unequivocal about the need for this shift. He regretted that the 1978 law had negatively impacted citizens, “From 1978 till now, government after government did not remember to amend that law to be in tune with current-day realities. And our people were languishing and dying in numbers over avoidable deaths because of lack of access to quality medicare and lack of access to technical manpower.”
In a historic partnership, the Imo State government in May 2025 signed agreements with global health solution providers, including Sepat Medical Investment and Management Company and JNC International Limited, with HHMC playing a supervisory and management role. Whereas Sepat maintains reputable global relationships, JNCI, in the same vein, connects to world-class manufacturers such as Canon Medical Systems, Olympus Corporation, Medtronic, Abbott Laboratories and Elekta.
